Abstract
This review highlights the multiple properties of the birch bark-derived pentacyclic triterpene betulin with special focus on its pharmacological activity in cancer and inflammation. While less well characterized compared to its hydrophilic derivative, betulinic acid, it exhibits potent anticancer activity described in many publications. Indeed, underinvestigated are its immunomodulatory functions in inflammatory diseases that appeared to enhance innate immune cell activities in an adjuvant-like fashion towards an interleukin-12 driven antitumor immunity. Herein, we like to emphasize the simultaneous and dual function of betulin on the basis of recent investigations of the tumor microenvironment and enlighten the potential use of betulin in the control of inflammation-associated carcinogenesis.
Keywords: Pentacyclic triterpene, betulin, dendritic cell, inflammation-associated carcinogenesis, cytostatic, immunomodulation.
Anti-Cancer Agents in Medicinal Chemistry
Title:Immunopharmacological Activity of Betulin in Inflammation-associated Carcinogenesis
Volume: 18 Issue: 5
Author(s): Anja Schwiebs*Heinfried H. Radeke
Affiliation:
- Institute of General Pharmacology and Toxicology, Immune Pharmacology, Pharmazentrum Frankfurt/ZAFES, Clinic of the Goethe University, Theodor-Stern-Kai 7, 60590 Frankfurt am Main,Germany
Keywords: Pentacyclic triterpene, betulin, dendritic cell, inflammation-associated carcinogenesis, cytostatic, immunomodulation.
Abstract: This review highlights the multiple properties of the birch bark-derived pentacyclic triterpene betulin with special focus on its pharmacological activity in cancer and inflammation. While less well characterized compared to its hydrophilic derivative, betulinic acid, it exhibits potent anticancer activity described in many publications. Indeed, underinvestigated are its immunomodulatory functions in inflammatory diseases that appeared to enhance innate immune cell activities in an adjuvant-like fashion towards an interleukin-12 driven antitumor immunity. Herein, we like to emphasize the simultaneous and dual function of betulin on the basis of recent investigations of the tumor microenvironment and enlighten the potential use of betulin in the control of inflammation-associated carcinogenesis.
Export Options
About this article
Cite this article as:
Schwiebs Anja *, Radeke H. Heinfried , Immunopharmacological Activity of Betulin in Inflammation-associated Carcinogenesis, Anti-Cancer Agents in Medicinal Chemistry 2018; 18 (5) . https://dx.doi.org/10.2174/1871520617666171012124820
DOI https://dx.doi.org/10.2174/1871520617666171012124820 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Regulatory Roles of Amino Acids in Immune Response
Current Rheumatology Reviews Disposition and Interaction of Biotherapeutics in Pediatric Populations
Current Drug Metabolism Alefacept
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Role of Chemokines in the Pathogenesis of Rheumatoid Arthritis
Current Rheumatology Reviews Design and Development of Nanovehicle-Based Delivery Systems for Preventive or Therapeutic Supplementation with Flavonoids
Current Medicinal Chemistry Generation, Subsets and Functions of Inducible Regulatory T Cells
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Effects of Carvedilol on the Expression of TLR4 and its Downstream Signaling Pathway in the Liver Tissues of Rats with Cholestatic Liver Fibrosis
Current Molecular Medicine Clinical Efficacy and Effectiveness of Ursodeoxycholic Acid in Cholestatic Liver Diseases
Current Clinical Pharmacology The Plasma Coagulation Cascade: Potential Targets for Novel Anticoagulants in Major Lower Limb Surgery
Current Vascular Pharmacology Tauopathies – Focus on Changes at the Neurovascular Unit
Current Alzheimer Research Revisiting the ABCs of Multidrug Resistance in Cancer Chemotherapy
Current Pharmaceutical Biotechnology The Role of Neurogenesis in Neurodegenerative Diseases and its Implications for Therapeutic Development
CNS & Neurological Disorders - Drug Targets Dengue Patients Treated with Doxycycline Showed Lower Mortality Associated to a Reduction in IL-6 and TNF Levels
Recent Patents on Anti-Infective Drug Discovery Recent Patents on Liposomal-Based Chemotherapeutics with a Triggered Release Mechanism
Recent Patents on Nanomedicine Pharmacological Risk Factors for Delirium after Cardiac Surgery: A Review
Current Neuropharmacology Counter-Current Chromatography for High Throughput Analysis of Natural Products
Combinatorial Chemistry & High Throughput Screening RAGE: A Potential Target for Aβ-Mediated Cellular Perturbation in Alzheimers Disease
Current Molecular Medicine Raxofelast, (±)5-(Acetyloxy)-2,3-dihydro-4,6,7-trimethyl-2-benzofuranacetic Acid: A New Antioxidant to Modulate the Inflammatory Response During Ischemia-Reperfusion Injury and Impaired Wound Healing
Mini-Reviews in Medicinal Chemistry A Cross-Docking Study on Matrix Metalloproteinase Family
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Nanocarriers in the Delivery of Hydroxychloroquine to the Respiratory System: An Alternative to COVID-19
Current Drug Delivery